christopher h. goss, md, ms, fccp
Division of Pulmonary and Critical Care Medicine
Professor of Pediatrics
University of Washington Medical Center
1959 N.E. Pacific, Campus Box 356522
Seattle, WA 98195-6522
Research Web Page
Academic Office: (206) 616-1058
Fax: (206) 685-8673
Clinic Appointments: (206) 598-4615
Education and Training
BA in Geology, Williams College, Williamstown, Massachusetts, 1985
MD, Univeristy of Colorado School of Medicine, Denver, Colorado, 1992
Internship and Residence in Internal Medicine, University of California at San Francisco, San Francisco, California 1995
Hospitalist Fellow in Internal Medicine, University of California at San Francisco, San Francisco, California 1996
Chief Resident in Internal Medicine, University of California at San Francisco, San Francisco, California 1997
MS in Epidemiology, University of Washington, Seattle, Washington 2000
Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington 2001
Cystic Fibrosis Research and Translation Center site
My research focuses on assessing predictors of survival in patients with cystic fibrosis and generating mathmatical models to predict survival in these patients. I am also involved in studying the changes of quality of life of patients with cystic fibrosis through time and integrating this information into the decision of these patients to pursue lung transplantation. Additional areas of interest have included the long-term mechanical ventilation outside of the intensive care unit and the epidemiology of acute respiratory distress syndrome. In addition to work in pulmonary and critical care epidemiology, I am the Associate Medical Director of the Cystic Fibrosis Therapeutics Development Network, a clinical trials network involving academic medical centers across the nation evaluating new and existing therapies for the treatment of patients with cystic fibrosis.
Goss CH, Aitken ML, Otto K, Rubenfeld GD. Detecting Stenotrophomonas maltophilia does not decrease survival in patients with Cystic Fibrosis. Am J Respir Crit Care Med. 2002 Aug 1;166(3):356-61
Nathens AB, Neff MJ, Goss CH, Maier RV, and Rivara FP. The effect of an older sibling and birth interval on the risk of childhood injury. Inj Prev, 2000; 6(3)219-23.
Goss CH, Mayer-Hamblett N, Kronmal RA, and Ramsey BW. The Cystic Fibrosis Therapeutics Development Network (CF TDN): A paradigm of a clinical trials network for genetic and orphan diseases. Adv Drug Deliv Rev. 2002 Dec 5;54(11):1505-28.
Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing Cystic Fibrosis lung transplant referral criteria using predictors of two year survival.Am J Respir Crit Care Med. 2002 Dec15;166(12 Pt 1):1550-5.
Goss CH. Airway clearance in cystic fibrosis Respir Care. 2003. Jan; 48(1):20-1.
Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States (in press, Critical Care Medicine).